BUCHAN JANE
Transaction: 05/22/2026
BUY
Change
+12,500
Price
$8.78
Filing
05/29/2026
Type
BUY
Immix Biopharma, Inc.
IMMX • Biotechnology
$13.91
▲ +0.08 (+0.58%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$887.06M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 10.01Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:07 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$13.91
Change0.58%
Shares Out63.77M
Market Cap$887.06M
Enterprise Value$655.95M
52W Range1.94 - 12.14
Beta0.11
P/E-22.22
P/B3.88
P/FCF-22.69
EV/EBITDA-15.84
EV/FCF-16.78
Price$13.91
Change0.58%
Shares Out63.77M
Market Cap$887.06M
Enterprise Value$655.95M
52W Range1.94 - 12.14
Beta0.11
P/E-22.22
P/B3.88
P/FCF-22.69
EV/EBITDA-15.84
EV/FCF-16.78
Earnings Yield-4.50%
FCF Yield-4.41%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio10.01
Quick Ratio10.01
Target$22.00
Target Upside58.16%
Target Median$22.00
Target Range19.00 - 25.00
Volume1.29M
Avg Volume1.51M
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
88/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 10.01Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
100/100
Bullish
Bullish
5
Hold
0
Bearish
0
Price Target
2026-08-16
Low
$19.00
Mean
$22.00
Median
$22.00
High
$25.00
Insider Transactions
Recent executive and insider activity
BUCHAN JANE
Transaction: 05/22/2026
BUY
Change
+6,250
Price
Not reported
Filing
05/29/2026
Type
BUY
Hsu Jason
Transaction: 05/22/2026
BUY
Change
+12,500
Price
$8.78
Filing
05/29/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| BUCHAN JANE | BUY | +12,500 | $8.78 | 05/22/2026 | 05/29/2026 |
| BUCHAN JANE | BUY | +6,250 | Not reported | 05/22/2026 | 05/29/2026 |
| Hsu Jason | BUY | +12,500 | $8.78 | 05/22/2026 | 05/29/2026 |
| Hsu Jason | BUY | +6,250 | Not reported | 05/22/2026 | 05/29/2026 |
| Chudnovsky Yekaterina | BUY | +6,250 | Not reported | 05/22/2026 | 05/29/2026 |
| Chudnovsky Yekaterina | BUY | +12,500 | $8.78 | 05/22/2026 | 05/29/2026 |
| Rachman Ilya M | BUY | +500,000 | $8.78 | 05/22/2026 | 05/29/2026 |
| CHANG NANCY T | BUY | +12,500 | $8.78 | 05/22/2026 | 05/29/2026 |
| CHANG NANCY T | BUY | +6,250 | Not reported | 05/22/2026 | 05/29/2026 |
| Morris Gabriel S | BUY | +500,000 | $8.78 | 05/22/2026 | 05/29/2026 |
| Marquet Magda | BUY | +12,500 | $8.78 | 05/22/2026 | 05/29/2026 |
| Marquet Magda | BUY | +6,250 | Not reported | 05/22/2026 | 05/29/2026 |
| Ng Carey | BUY | +12,500 | $8.78 | 05/22/2026 | 05/29/2026 |
| Ng Carey | BUY | +6,250 | Not reported | 05/22/2026 | 05/29/2026 |
| Adams Helen C. | BUY | +12,500 | $8.78 | 05/22/2026 | 05/29/2026 |
| Adams Helen C. | BUY | +6,250 | Not reported | 05/22/2026 | 05/29/2026 |
| CHANG NANCY T | BUY | +39,643 | $4.33 | 11/21/2025 | 12/11/2025 |
| Morris Gabriel S | BUY | +770 | $6.58 | 12/10/2025 | 12/10/2025 |
| Rachman Ilya M | BUY | +746 | $6.67 | 12/10/2025 | 12/10/2025 |
| Morris Gabriel S | SELL | -60,000 | $0.80 | 12/08/2025 | 12/10/2025 |